China Law and Practice4d
In the News: Pharma Data Protection Rules; Facial Recognition Restrictions; and UBS Fully Owns Its Chinese Operations
China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate ...
China Law and Practice6d
Illumina’s Inclusion in China’s Unreliable Entity List: Patent Wars, Geopolitical Risks, and Compliance Strategies
Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s ...
China Law and Practice5h
State Council, Provisions for Handling Foreign-Related Intellectual Property Disputes
State Council restricts provision of evidence outside of mainland China for IP cases / CLP Reference: 5100/25.03.13 ; Promulgated: 2025-03-13 ; Effective: 2025-05-01 ...